Month: May 2021
Tetra Bio-Pharma (OTC: TBPMF) Announces Clinical Advancements and Establishment of At-the-Market Equity Program
First REBORN1© patient enters clinical trial. Positive results of first study in Sars-CoV-2 infected mice. Filing of IND for ARDS-003 Adaptive Phase 1a/1b clinical trial. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ […]